Kelly co-founded Testing For All in 2020 and scaled it to becoming a leading Covid-19 test provider, with £29m turnover. Prior to this, Kelly was a strategic advisor to large diagnostics players such as BD, Abbott and Biomérieux.
Kelly co-founded Testing For All in 2020 and scaled it to becoming a leading Covid-19 test provider, with £29m turnover. Prior to this, Kelly was a strategic advisor to large diagnostics players such as BD, Abbott and Biomérieux.